67 FR 178 pg. 58066 - Prospective Grant of Exclusive License: P2X7: Receptor Antagonists; Correction
Type: NOTICEVolume: 67Number: 178Page: 58066
FR document: [FR Doc. 02-23333 Filed 9-12-02; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive License: P2X 7 : Receptor Antagonists; Correction
A notice published in the August 29, 2002 Federal Register -announcing the prospective grant of an exclusive license for the use of P2X 7 receptor antagonists (67 FR 55415)-incorrectly listed the receipt date for comments/license applications as "October 28, 2002" under the DATES section. This notice serves to correct the date to reflect a 90-day review period rather than a 60-day review period. To allow interested parties adequate time to respond, NIH is publishing this notice to amend the DATES : section to read: "Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before December 12, 2002, will be considered."
Dated: September 3, 2002.
Jack Spiegel,
Director, Division of Technology Development and Transfer, Office of Technology Transfer.
[FR Doc. 02-23333 Filed 9-12-02; 8:45 am]
BILLING CODE 4140-01-P